Title |
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque
|
---|---|
Published in |
Scientific Reports, February 2018
|
DOI | 10.1038/s41598-018-22076-4 |
Pubmed ID | |
Authors |
Roberto Carnevale, Cristina Nocella, Vincenzo Petrozza, Vittoria Cammisotto, Luca Pacini, Veronica Sorrentino, Ombretta Martinelli, Luigi Irace, Sebastiano Sciarretta, Giacomo Frati, Daniele Pastori, Francesco Violi |
Abstract |
Experimental studies showed that gut-derived lipopolysaccharide (LPS) is pro-atherogenic, however, its relationship with human atherosclerosis is still to be defined. We investigate if gut-derived LPS from Escherichia Coli localizes in human carotid plaque and its potential role as pro-inflammatory molecule in the atherosclerotic lesion. LPS from Escherichia Coli and Toll-like receptor 4 (TLR4) were studied in specimens from carotid and thyroid arteries of 10 patients undergoing endarterectomy and 15 controls matched for demographic and clinical characteristics. Blood LPS were significantly higher in patients compared to controls. Immunochemistry analysis revealed positivity for antibodies against LPS and TLR4 coincidentally with positivity for CD68 only in the atherosclerotic plaque of carotid arteries but not in thyroid arteries; the positivity for LPS and TLR4 was greater in the area with activated macrophages. LPS concentration similar to that detected in atherosclerotic plaque resulted in a dose-dependent TLR4-mediated Nox2 up-regulation by human monocytes. These data provide the first evidence that LPS from Escherichia Coli localizes in human plaque and may contribute to atherosclerotic damage via TLR4-mediated oxidative stress. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Canada | 1 | 17% |
Unknown | 3 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 3 | 50% |
Members of the public | 2 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 79 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 16% |
Student > Bachelor | 12 | 15% |
Student > Doctoral Student | 8 | 10% |
Student > Ph. D. Student | 7 | 9% |
Student > Master | 7 | 9% |
Other | 15 | 19% |
Unknown | 17 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 25% |
Biochemistry, Genetics and Molecular Biology | 12 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
Agricultural and Biological Sciences | 3 | 4% |
Neuroscience | 2 | 3% |
Other | 6 | 8% |
Unknown | 30 | 38% |